Kkr & CO INC Form 4 insider transactions

KKR Alternative Assets LLC, an affiliate of KKR, acquired over 121,000 shares of KKR Real Estate Select Trust Inc. common stock as payment for management fees.

KKR & Co. Inc. Director Craig Arnold was granted 242 restricted stock units under the company's 2019 Equity Incentive Plan, vesting on December 1, 2025.

KKR Alternative Assets LLC acquired over 57,000 shares of KKR Real Estate Select Trust Inc. common stock as payment for advisory fees.

KKR & Co. Inc. Co-Chief Executive Officer Scott C. Nuttall reported a transfer of 194,000 shares of common stock to a family trust.

KKR & Co. Inc. Co-Chief Executive Officer Joseph Bae reported an intra-family transfer of 398,335 common shares to a family trust, effective August 29, 2025.

KKR's Chief Financial Officer, Robert H. Lewin, reported a future disposition of 2,500 common shares as a charitable gift.

KKR Group Partnership L.P. and its affiliates entered into an equity swap for 1.87 million Henry Schein shares, signaling a substantial investment.

KKR Co-Chief Executive Officer Joseph Y. Bae's family trust acquired 1,592 shares of KKR & Co. Inc. common stock from other family members for $227,250.04, effective August 8, 2025.

KKR & Co. Inc. Co-Executive Chairman George R. Roberts reported the sale of 809,906 shares of common stock for approximately $117 million, while affirming no further sales planned for 2025.

KKR Alternative Assets LLC acquired over 56,000 shares of KKR Real Estate Select Trust Inc. common stock as payment for management and incentive fees.

KKR Alternative Assets LLC, an affiliate of KKR, acquired over 121,000 shares of KKR Real Estate Select Trust Inc. common stock as payment for management and incentive fees.

KKR Group Partnership L.P. and affiliated entities, significant shareholders and directors of BrightSpring Health Services, Inc., reported the sale of 2.1 million common shares as part of a secondary public offering's over-allotment option.

KKR Group Partnership L.P. and affiliated entities have disclosed an equity swap agreement for 57,348 notional shares of Henry Schein Inc. common stock, indicating a structured investment approach.

KKR Group Partnership L.P. and affiliated entities, including founders Henry R. Kravis and George R. Roberts, reported the sale of 13,288,101 shares of BrightSpring Health Services, Inc. common stock at a net price of $21.1519 per share, alongside significant in-kind distributions and charitable donations.

KKR Group Partnership L.P. and its affiliated entities reported the sale of 11.6 million shares of BrightView Holdings, Inc. common stock at $14.40 per share, reducing their beneficial ownership to 21.53 million shares, as part of a Rule 10b5-1(c) plan.

KKR Alternative Assets LLC and related entities acquired over 55,000 shares of KKR Real Estate Select Trust Inc. common stock as payment for management and incentive fees.

KKR & Co. Inc.'s Co-Executive Chairman, George R. Roberts, reported the sale of 1,190,094 shares of common stock at $119.8 per share, while retaining significant beneficial ownership.

KKR & Co. Inc.'s Co-Executive Chairman and 10% owner, Henry R. Kravis, has reported the sale of 1,281,394 shares of common stock for approximately $154 million, executed under a Rule 10b5-1 trading plan.

KKR & Co. Inc. Director and 10% Owner Timothy R. Barakett has purchased 35,000 shares of common stock for approximately $4.13 million, signaling strong insider confidence in the firm's future.

Henry Kravis, Co-Executive Chairman of KKR & Co. Inc., filed a Form 4 detailing changes in his beneficial ownership of KKR common stock, including transfers for estate planning and charitable donation purposes.

George R. Roberts, Co-Executive Chairman of KKR & Co. Inc., reports the donation of 200,000 shares of KKR common stock to a charitable foundation.

Scott Nuttall, Co-CEO of KKR & Co. Inc., filed a Form 4 detailing changes in his beneficial ownership of KKR common stock due to transfers and trust activities.

Robert Lewin, CFO of KKR & Co. Inc., reports donating 10,000 shares of common stock to a charitable organization on May 15, 2025.

Joseph Bae, Co-CEO of KKR & Co. Inc., reported changes in his beneficial ownership of KKR common stock due to family trust transfers and other transactions.

KKR Genetic Disorder L.P. sold 6 million shares of BridgeBio Pharma at $34.20 per share.

Robert Scully, a director at KKR & Co. Inc., reported the acquisition of 13,250 shares of common stock at an average price of $113.4893 on May 6, 2025.

KKR Alternative Assets LLC acquired 52,613.841 shares of KKR Real Estate Select Trust Inc. common stock at $24.26 per share as payment for management and incentive fees.

KKR Group Partnership L.P. and related entities reported the acquisition of Class A Common Stock of Crescent Energy Co through the redemption of OpCo LLC Units.

KKR Alternative Assets LLC acquired 117,903 shares of KKR Real Estate Select Trust Inc. common stock as payment for management and/or incentive fees.

Henry Kravis, Co-Executive Chairman of KKR & Co. Inc., reported a transfer of common stock to a family trust and other transactions affecting his beneficial ownership.